Entresto 49 MG-51 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJ1YT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,903
Award facts
- Contract value 100% obligated
- $18,903.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,903.32 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (60-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. Through its extensive federal contract portfolio with DLA, the company supplies diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. The delivery order for Entresto, a cardiac medication, reflects the company's capability to fulfill specialized pharmaceutical requirements through open competition and demonstrates its role as a key provider within the DLA's medical supply chain serving military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJ1YT?
SPE2DB25FJ1YT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FJ1YT worth?
The government has obligated $18,903 on SPE2DB25FJ1YT.
Is contract SPE2DB25FJ1YT an order under another contract?
Yes. SPE2DB25FJ1YT is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ1YT competed?
The extent of competition for SPE2DB25FJ1YT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award